Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07811063) titled 'A Study to Test a Single Dose of a New Tablet Formulation of TRTL-729' on Sept. 2.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Basic Science. Masking: None (Open Label).
Primary Sponsor: Tortugas Neuroscience, Inc.
Condition:
Healthy Volunteers
Intervention:
Drug: TRTL-729
Recruitment Status: Not recruiting
Phase: Phase 1
Date of First Enrollment: September 2026
Target Sample Size: 10
Countries of Recruitment:
New Zealand
To know more, visit https://clinicaltrials.gov/study/NCT07811063
Disclaimer: Curated by HT Syndication....